Impact of culprit plaque morphology on clinical outcome after drug-coated balloon treatment for patients with acute coronary syndromes.

Impact of culprit plaque morphology on clinical outcome after drug-coated balloon treatment for patients with acute coronary syndromes. - Impact of culprit plaque morphology on clinical outcome after drug-coated balloon treatment for patients with acute coronary syndromes.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049605

Enrollment

127

Registered

2023-01-16

Start date

2023-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients whose culprit lesions were treated with DCB 2. patients with ACS who underwent OCT guided PCI 3. patients over 20 years old.

Exclusion criteria

Exclusion criteria: (1) patients treated with stent (2) patients with in-stent restenosis or stent thrombosis; (3) patients with shock status; (4) patients with target lesion in a left main coronary artery; (5) patients with coronary artery bypass grafted lesions; (6) patients with missing data; (7) patients with insufficient OCT data quality: and (8) patients with life expectancy < 1 year.

Design outcomes

Primary

Measure	Time frame
target lesion failure: TLF	—

Countries

Japan

Contacts

Public ContactTetsuya Yamamoto

Kobe University Graduate School of Medicine Division of Cardiovascular Medicine, Department of Internal Medicine

m07100ty@jichi.ac.jp078-382-5846

Outcome results